<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> is rising rapidly in incidence and usually develops from <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, a precursor condition commonly found in patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">acid reflux</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0850639" disease_type="Neoplastic Process" abbrv="">Premalignant lesions</z:e> are challenging to detect on conventional screening endoscopy because of their flat appearance </plain></SENT>
<SENT sid="2" pm="."><plain>Molecular changes can be used to improve detection of early <z:hpo ids='HP_0002664'>neoplasia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>We have developed a <z:chebi fb="7" ids="16670">peptide</z:chebi> that binds specifically to high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>We first applied the <z:chebi fb="7" ids="16670">peptide</z:chebi> ex vivo to esophageal specimens from 17 patients to validate specific binding </plain></SENT>
<SENT sid="5" pm="."><plain>Next, we performed confocal endomicroscopy in vivo in 25 human subjects after topical <z:chebi fb="7" ids="16670">peptide</z:chebi> administration and found 3.8-fold greater fluorescence intensity for esophageal <z:hpo ids='HP_0002664'>neoplasia</z:hpo> compared with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and squamous epithelium with 75% sensitivity and 97% specificity </plain></SENT>
<SENT sid="6" pm="."><plain>No toxicity was attributed to the <z:chebi fb="7" ids="16670">peptide</z:chebi> in either animal or patient studies </plain></SENT>
<SENT sid="7" pm="."><plain>Therefore, our first-in-human results show that this targeted imaging agent is safe and may be useful for guiding tissue biopsy and for early detection of esophageal <z:hpo ids='HP_0002664'>neoplasia</z:hpo> and potentially other <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> of epithelial origin, such as bladder, colon, lung, pancreas, and stomach </plain></SENT>
</text></document>